Infusion of a mu opioid receptor (MOR) agonist into the nucleus accumbens (NAcc) drives voracious food intake, an effect hypothesized to occur through increased tastant palatability. While intake of many palatable foods is elevated by MOR stimulation, this manipulation has a preferential effect on fatty food ingestion. Consumption of high-fat foods is increased by NAcc MOR stimulation even in rats that prefer a carbohydrate-rich alternative under baseline conditions. This suggests that NAcc MOR stimulation may not simply potentiate palatability signals and raises the possibility that mechanisms mediating fat intake may be distinct from those underlying intake of other tastants. The present study was conducted to investigate the physiological mechanisms underlying the effects of NAcc MOR stimulation on fatty food intake. In Experiment 1, we analyzed lick microstructure in rats ingesting Intralipid to identify the changes underlying feeding induced by infusion of a MOR-specific agonist into the NAcc. MOR stimulation in the NAcc core but not shell increased burst duration and first-minute licks, while simultaneously increasing the rate and duration of Intralipid ingestion. These results suggest that MOR activation in the core increases Intralipid palatability and attenuates inhibitory post-ingestive feedback. In Experiment 2, we measured the effects of MOR stimulation in the NAcc core on consumption of non-nutritive Olestra. A MOR-specific agonist dose-dependently increased Olestra 
Introduction
Understanding the neural mechanisms that promote food intake exceeding metabolic need is a fundamentally important step in addressing the growing health problem of overweight and obesity.
While food intake is determined by the convergence of many neural signaling pathways (31) , central opioid signaling acting in motivation/reward circuits may be particularly important in driving excessive food consumption, as these brain circuits are involved in determining the reinforcing value of tastants (3, 24, 28) .
Activation of mu opioid receptors (MORs) in the nucleus accumbens (NAcc) constitutes a particularly potent stimulus for food intake. Even in satiated rats, infusion of the MOR-specific agonist [D-Ala2, NMePhe4, Gly-ol]-enkephalin (DAMGO) into the NAcc increases food intake (2, 29, 42, 44) . This behavioral effect is hypothesized to occur through opioid-induced increases in tastant palatability.
Several convergent lines of evidence support this hypothesis. First, NAcc MOR stimulation increases intake of palatable tastants such as high-fat chow, sucrose, and saccharin, but has little effect on substances with hedonically neutral tastes, such as water or standard rat chow (24, 46) . This finding is consistent with a mechanism in which MOR activation potentiates palatability-related signals. Second, DAMGO infusion into the NAcc increases positive taste reactivity displays occurring in response to an intraorally infused sucrose solution (27, 28, 37) . These orofacial reactions are correlated with the hedonic impact of tastants (19) , suggesting MOR stimulation increases the palatability of the sucrose solution. Third, analysis of lick microstructure indicates that elevated sucrose consumption following infusion of DAMGO into the NAcc occurs through increases in the duration of licking bursts (41) .
Previous work has shown that burst duration covaries with tastant palatability, with more preferred tastants eliciting longer burst durations (14, 39) . Together, these findings suggest increases in palatability underlie consumption driven by NAcc MOR stimulation.
While NAcc MOR stimulation can increase intake of many food items, it is particularly effective as well as selective in increasing the intake of fatty foods. In animals offered a choice of high-fat or highcarbohydrate foods, infusion of DAMGO into the NAcc selectively increases consumption of the high-fat diet (44) . This selective effect is independent of baseline preference, as even carbohydrate-preferring rats more than triple their average consumption of the high-fat diet, without significant changes in consumption of the high-carbohydrate diet. This finding has interesting implications for the mechanisms underlying opioid effects in the NAcc on food intake. Specifically, it challenges the idea that opioidinduced hyperphagia results solely through potentiation of palatability signals -if this were the case, NAcc DAMGO would be expected to increase consumption of preferred foods, independent of macronutrient content.
The independence of NAcc MOR-induced hyperphagia from baseline preference raises the possibility that the physiological mechanisms underlying potentiation of fatty food intake may differ from those supporting increased consumption of other palatable tastants. To investigate this possibility, we performed a series of experiments designed to elucidate the physiological mechanisms underlying the effects of NAcc MOR stimulation on consumption of fatty tastants. In Experiment 1, we used lick microstructure analysis during consumption of a palatable fat emulsion to compare concentrationdependent changes in palatability to hyperphagia induced by NAcc DAMGO infusion. In Experiment 2,
we assessed the effects of NAcc MOR stimulation on consumption of noncaloric Olestra. Finally, in Experiment 3, we assessed interactions between NAcc DAMGO-induced hyperphagia and melanocortinmediated satiety signals.
Materials and methods
Animals and experimental overview. Individually housed male Sprague-Dawley rats (n=86; 350-550 grams) maintained on a 12-12 light-dark cycle (lights on at 7 AM) were used in all experiments. Rats were allowed ad libitum access to food (8640 Teklad 22/5 Rodent Diet, Harlan, Indianapolis, IN) and water throughout the experimental period. Rats were used in four experiments: studies of 1) lick microstructure (Experiment 1a, Intralipid concentration series, n = 16 rats; Experiment 1b, NAcc DAMGO infusion, n = 19 for core infusions, n = 14 for shell infusions); 2) noncaloric Olestra intake (n=12); 3) interaction of DAMGO and the melanocortin agonist MTII signaling (n=16); and 4) the effects of pretreatment with the MOR-specific antagonist D-Phe-Cys-Trp-Arg-Thr-Pen-Thr-NH 2 (CTAP) on DAMGOinduced hyperphagia (n=9 rats for studies of Olestra intake, n = 12 rats for studies of Intralipid intake).
Rats used in experiment 2 were a subset of those used in experiment 3, but different groups were used for other experiments. Longer epochs of consumption, meals, were defined by ILIs < 10 m. Meal duration was measured by the time elapsed from the first to the last lick of a meal. In addition, the latency to begin licking was defined as the time elapsed from the session start time until the first lick of a meal. Finally, first-minute licks were quantified to capture licking behavior early in the session, before inhibitory feedback from postingestive signaling could suppress consumption. Like burst duration, initial lick rate has been shown to covary with tastant palatability (11, 35 For data gathered in Experiment 1b, statistical analyses of the same dependent variables were carried out with DAMGO concentration as the independent variable. One-way RM ANOVA was used for all tests except for burst duration, for which RM ANOVA on ranks was performed. Data from Experiment 2 were analyzed using RM ANOVA on ranks, with DAMGO concentration as the independent variable and Olestra intake as the dependent variable. One-way RM ANOVA was used to analyze data collected in Experiment 3 to determine the effects of drug treatment (independent variable) on total consumption and latency to begin feeding (dependent variables). The time course of feeding was analyzed using twoway RM ANOVA with drug treatment and time as independent variables and time spent feeding as the dependent variable. One-way RM ANOVA was used to analyze data collected in Experiment 4 to determine the effects of drug treatment (independent variable) on consumption (dependent variable).
Except where noted, the Holm-Sidak method was used for post-hoc testing.
Histology. Rats were deeply anesthetized with sodium pentobarbital (Beuthenasia-D, 40 mg/kg) and perfused first with physiological saline and then 4% formaldehyde. Brains were extracted, cryoprotected overnight in 30% sucrose, and cryostat sectioned. Sections were stained with methyl red to anatomically localize cannula placements. Cannulae directed at the NAcc shell were mislocalized in one rat. Data from this rat were excluded from further analysis.
Results.
Experiment 1a: Lick microstructure during consumption of Intralipid concentration series.
In our initial experiment, we characterized lick microstructure as a function of concentration-dependent changes in palatability during consumption of Intralipid. Results from this experiment provided a context for understanding NAcc DAMGO-induced changes in licking behavior, studied in Experiment 1b. Infusion of DAMGO into the NAcc core more effectively increased Intralipid consumption than infusion into the shell (Figures 3-4) . We therefore targeted only core infusion sites in Experiments 2 and 3.
Infusion of DAMGO into the NAcc core dose-dependently increased consumption of Olestra during 30 minute sessions ( Figure 6A ; main effect of drug concentration, χ relative to control infusions, causing a 50% decline in intake (mean ±SEM of 7.1±0.7 vs. 3.6±0.8 grams, p<0.05). When DAMGO was co-infused with MTII, it reversed this suppression of food intake but did not cause hyperphagia: consumption was significantly higher than that following saline+MTII infusion, but still lower than that measured after DAMGO+saline infusions (both p<0.05). In some behavioral contexts, DAMGO infusion into the NAcc causes a transient suppression of feeding before subsequent hyperphagia (24, 41) . However, we found that DAMGO+saline infusions resulted in a significant decrease in the latency to begin consumption of high-fat chow ( Figure 7C , main effect of drug χ 2 (3) = 15.7, p = 0.001). MTII alone had no effect on the latency to begin feeding (p > 0.05 compared to control saline), but coinfusion of MTII with DAMGO reversed the rapid onset of feeding caused by DAMGO, restoring the latency to begin feeding to control levels (p > 0.05, compared to control saline).
Infusion sites for all experiments were confined to targeted core and shell subregions of the NAcc (Figure 8) .
Discussion
Our results demonstrate that Intralipid consumption induced by DAMGO infusion into the NAcc is associated with changes in lick microstructure suggestive of increased palatability -specifically, increased burst duration and first-minute licks. Both of these parameters, as well as the total volume of Intralipid consumed, were robustly increased following MOR stimulation in the NAcc core but not the shell. This finding is consistent with a previous mapping study demonstrating greater sensitivity of core vs. medial shell sites to DAMGO-induced hyperphagia (45) . Notably, however, mapping studies utilizing morphine infusion to induce hyperphagia suggest that medial shell sites tend to be more effective than core sites in eliciting hyperphagia (2, 28) . Pharmacological differences in the agonist as well as doses used may account for these divergent results.
Our finding of a primary role for the NAcc core in opioid-induced hyperphagia runs counter to the general proposal that shell and core regions show functional specialization for, respectively, rewardrelated processing and motor-associated function (16, 23, 43) . Considerable evidence supports this hypothesis (8, 22, 33) ; however, our data suggest that opioid effects on food intake may not conform to this general pattern. Our results show that DAMGO infusion into the NAcc core potently increases palatability-associated lick microstructure parameters of burst duration and first-minute licks, while infusion into the medial shell has much more modest effects. Previous work has shown that positive taste reactivity displays are increased following DAMGO infusion into the NAcc shell (27) ; to our knowledge, however, similar experiments have not been carried out following infusion into the NAcc core, and so the relative sensitivity of these sites to the effects of MOR stimulation on hedonic taste reactivity is unknown. Interestingly, palatability-related electrophysiological responses are found in both the core and shell regions (30, 40) , supporting potential roles for both areas in taste reward.
Because core infusions of DAMGO most effectively induced hyperphagia in lick microstructure experiments, we focused on this area in subsequent experiments. Taken together, results from these experiments support a two-part mechanism for hyperphagia elicited by stimulation of MORs in the NAcc core during consumption of a fatty tastant. Our analysis of lick microstructure showed that both burst duration and first-minute licks, each of which has previously been shown to covary with tastant palatability (14, 39) , were dose-dependently increased by infusion of DAMGO into the NAcc core ( Figure   4A -B). These changes paralleled those observed after concentration-dependent increases in palatability (Figure 2A-B) . In addition, NAcc MOR stimulation increased consumption of noncaloric Olestra ( Figure   6 ). This latter finding suggests that orosensensory cues alone are a sufficient substrate for opioidpotentiated consumption, which clearly can occur in the absence of postingestive signaling derived from caloric content. Together these data provide evidence that increases in tastant palatability play a primary role in expression of NAcc DAMGO-induced hyperphagia for fatty foods.
Results from our lick microstructure experiments suggest that MOR stimulation in the NAcc core also attenuated satiety-related inhibitory feedback, resulting in extended periods of consumption. Inhibitory post-ingestive signaling decreases licking rates, meal duration and burst number (13) (14) (15) ; decreases in the latter two measures were evident when comparing lick microstructure during 10% vs. 1% Intralipid intake ( Figures 1C and 2C) . DAMGO infusion generally acted to counter these changes associated with satiety-related signaling. Infusion of a high dose of DAMGO (125 ng/NAcc) into the core resulted in sustained elevation of lick rates ( Figure 3B ) and maintained meal duration and burst number at levels similar to those occurring after control saline infusion ( Figures 3C and 4C ). In addition, infusion of NAcc DAMGO was able to reverse the suppressive effects of intracerebroventricular infusion of MTII on highfat chow intake ( Figure 7A ). These results show that suppression of satiety-related signaling contributes to the hyperphagia observed after NAcc DAMGO infusion.
Comparing NAcc DAMGO effects on intake of high-fat vs. high-carbohydrate foods. The effects of NAcc DAMGO on lick microstructure during fatty tastant intake were qualitatively similar to those that occurred during sucrose consumption, which we described in a previous study (41) . For both sucrose and Intralipid consumption, hyperphagia induced by DAMGO infusion into the NAcc was associated with increased burst duration, suggesting that palatability-related changes play a central role in increasing consumption after NAcc MOR stimulation, independent of the macronutrient content of the solution ingested.
Previous studies have shown that NAcc MOR stimulation preferentially increases high-fat chow intake, even in rats that show baseline preferences for a high-carbohydrate alternative (44) . This suggests that mechanisms underlying hyperphagia mediated by NAcc MOR stimulation may not be mediated exclusively by changes to tastant palatability, provided that palatability itself is a principal driver of baseline food preference. In particular, this behavioral finding suggests that DAMGO is unlikely to act simply by potentiating palatability-related neural responses that have been identified in a subset of NAcc neurons (30, 40) . Our results, however, suggest qualitatively similar changes relating chiefly to increases in palatability cause DAMGO-induced hyperphagia of both Intralipid and sucrose, albeit with some differences in the magnitude of the changes induced. A number of potential mechanisms could underlie the observed similarity in NAcc DAMGO effects on sucrose and Intralipid. It may be, for instance, that there is some segregation of palatability responses evoked by sweet and fatty tastants in the NAcc, and that these types of responses differ in their sensitivity to MOR stimulation.
Electrophysiological studies of NAcc responses to fatty and sweet tastants will be important in addressing this possibility. It is interesting to consider the potential mechanisms through which NAcc DAMGO alters both palatability and satiety-related signaling. An obvious possibility is that initial changes in palatability are required for ensuing changes in satiety and that the DAMGO-induced increases in the hedonic impact of food items drives suppression of satiety signaling. However, an alternative possibility is that NAcc MOR stimulation elicits changes in palatability and satiety signaling in parallel, rather than through serial signaling. Consistent with this possibility, previous studies have shown that NAcc DAMGO effects on hyperphagia and taste reactivity can be dissociated anatomically (27, 38) . MOR stimulation in a circumscribed portion of the NAcc shell increases both food intake and positive taste reactivity; however, stimulation in the surrounding volume of the NAcc increases food intake without concurrent increases in taste reactivity. Provided that changes in taste reactivity are a faithful index of palatability (5) , this result suggests that NAcc MOR stimulation is capable of eliciting increased consumption independent of changes in palatability.
Perspectives and Significance. The growing prevalence of overweight and obesity pose a dangerous threat to health. Palatability-driven consumption of abundantly available, inexpensive, energy-dense foods is an important contributor to intake in excess of metabolic demand (26, 47) . MOR stimulation in the NAcc may play an important role in this process, as it drives an intense hyperphagia and moreover selectively promotes consumption of high-fat foods, which are an important driver of weight gain in humans (6, 24, 44 ). Our results demonstrate that MOR stimulation in the NAcc core induces hyperphagia, driven by increased palatability of fatty tastants independent of post-ingestive caloric signaling. Further, we show that MOR activation in the NAcc core is sufficient to partially reverse satiety signaling induced by the melanocortin agonist MTII. Future work focused on mechanisms through which MOR stimulation suppresses satiety signaling will be important in understanding root causes of weight gain caused by palatability-driven intake. 
